● Recruiting

Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

Condition: Ischemic Heart Disease · Sponsor: Roberto Bolli

PhasePhase 2

Planned participants60

Who can joinAll sexes, 21 Years to 85 Years

Healthy volunteersNo

About this study

This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs, stem cells), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic cardiomyopathy (ICM).

This description comes directly from the study's public registry record.

Talk to the study team

Roberto Bolli, MD · 502-608-5426 · rbolli@louisville.edu

Michelle Unseld, RN · 502-540-3423 · michelle.unseld@louisville.edu

Always discuss trial participation with your own doctor first.

Locations (3)

University of Miami Miller School of Medicine	Miami, Florida, United States	Recruiting
University of Louisville School of Medicine, Institute of Molecular Cardiology	Louisville, Kentucky, United States	Recruiting
The Texas Heart Institute Houston Texas	Houston, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06145035